{{trivia|time=2018-02-04T15:14:16+00:00}}
{{Infobox_Person
| name = 王陸海
|image= 
|box_width= 260px
|occupation= [[腫瘤學|腫瘤學]]學者
| period = 1947 -
| english_names = Wang , Lu-Hai
| Sex = 男
|birth_date= {{birth year and age|1947}}
|birth_place= {{TWN}}[[雲林縣|雲林縣]][[斗南鎮|斗南鎮]]<ref>[https://www.cna.com.tw/postwrite/Detail/244556.aspx 探索生命的未知 中國醫藥大學副校長王陸海院士堅持有毅力樂此不疲] {{Wayback|url=https://www.cna.com.tw/postwrite/Detail/244556.aspx |date=20210714063126 }}，中央通訊社，2018-11-14</ref>
|death_date= 
|death_place= 
|nationality= {{ROC}}
| religion =
| spouse = 
| relatives = 
|education= 
*[[雲林縣斗南鎮斗南國民小學|雲林縣斗南國民學校]]
*[[國立嘉義高級中學|臺灣省立嘉義中學]]
*[[國立臺灣大學動物學系|國立臺灣大學動物學系]]學士<span style="color: blue;">（1970年）</span>
*[[美國|美國]][[柏克萊加州大學|柏克萊加州大學]]分子生物學博士<span style="color: blue;">（1976年）</span>
| past = 
*加州大學柏克萊分校分子生物學博士<br /><span style="color: blue;">（1976年-1977年）</span>
*美國洛克菲勒大學博士後研究員<br /><span style="color: blue;">（1977年-1979年）</span>
*美國洛克菲勒大學助理教授<span style="color: blue;">（1979年-1985年）</span>
*美國西奈山醫學院微生物學副教授<br /><span style="color: blue;">（1985年-1988年）</span>
*美國國立衛生研究院研究員<br><span style="color: blue;">（1986年-1992年）</span>
*美國西奈山醫學院微生物學終身教職副教授<br /><span style="color: blue;">（1988年-1992年）</span>
*美國衛生研究院考研審稿儲備<br><span style="color: blue;">（1992年-）</span>
*美國西奈山醫學院微生物學、腫瘤學科學教授<br /> <span style="color: blue;">（1992年-）</span>
*美國西奈山醫學院癌症中心教授<br><span style="color: blue;">（1999年-2004年）</span>
*台灣國家衛生研究院特聘研究員兼主任<br><span style="color: blue;">講座教授（2008年-）</span>
*台灣國家衛生研究院特聘研究員<br><span style="color: blue;">專案講座教授（2017年-）</span>
*台灣中國醫藥大學副校長暨中西結合研究所教授<br><span style="color: blue;">講座教授（2017年-）</span>
{{Infobox_People_Sinica
|组别=生命科學組
|届数=第28屆
|当选年=2010年
}}
}}
'''王陸海'''（{{bd|1947年||}}），台湾[[分子生物學家|分子生物學家]]和[[腫瘤學家|腫瘤學家]]。

==生平==
出生於[[台灣|台灣]]，曾為美國[[西奈山|西奈山]]醫學中心微生物學、癌症中心、腫瘤科學系正教授，回台灣進入[[國家衛生研究院|國家衛生研究院]] (代理院長)、[[中央研究院|中央研究院]]院士<ref>{{Cite web|url=https://db1n.sinica.edu.tw/textdb/academicians/02.php?func=22&_op=?ID:L101|title=院士會議|accessdate=2018-03-09|work=db1n.sinica.edu.tw|archive-url=https://web.archive.org/web/20180310010222/https://db1n.sinica.edu.tw/textdb/academicians/02.php?func=22&_op=%3FID%3AL101|archive-date=2018-03-10|dead-url=yes}}</ref>，2012年當選[[TWAS|TWAS]] (The Academy of Sciences for the developing world, TWAS[[發展中世界科學院|發展中世界科學院]])院士。主要研究[[癌症防治|癌症防治]]、[[腫瘤學|腫瘤學]]、[[分子生物學|分子生物學]]。現為中國醫藥大學副校長暨中醫學院中西醫結合研究所講座教授<ref>{{Cite web|url=http://president.cmu.edu.tw/vice-president_Wang.html|title=中國醫藥大學 校長室 China Medical University, Taiwan|accessdate=2018-03-09|work=president.cmu.edu.tw|archive-url=https://web.archive.org/web/20180310010755/http://president.cmu.edu.tw/vice-president_Wang.html|archive-date=2018-03-10|dead-url=yes}}</ref>，國立臺灣大學分子與細胞生物學研究所、國立中央大學生命科學系<ref>{{Cite web|url=http://in.ncu.edu.tw/ls/nculs/teacher_4.php|title=國立中央大學 生命科學系|accessdate=2018-03-09|work=in.ncu.edu.tw|language=en|archive-url=https://web.archive.org/web/20180310010654/http://in.ncu.edu.tw/ls/nculs/teacher_4.php|archive-date=2018-03-10|dead-url=yes}}</ref>與清華大學<ref>{{Cite web|url=http://mm.life.nthu.edu.tw/people/bio.php?PID=136|title=王陸海的個人資料 - 國立清華大學 生命科學院 分子醫學研究所|accessdate=2018-03-09|work=mm.life.nthu.edu.tw|language=zh-tw|archive-url=https://web.archive.org/web/20180310073947/http://mm.life.nthu.edu.tw/people/bio.php?PID=136|archive-date=2018-03-10|dead-url=yes}}</ref>兼任教授，同時也是美國華陽生命科學股份有限公司 (Sun Farm Corp.) 科學委員、億康生物科技股份有限公司董事<ref>{{Cite web|url=http://tw.wikiinc.net/%E5%84%84%E5%BA%B7%E7%94%9F%E7%89%A9%E7%A7%91%E6%8A%80%E8%82%A1%E4%BB%BD%E6%9C%89%E9%99%90%E5%85%AC%E5%8F%B8/28516838|title=億康生物科技股份有限公司|accessdate=2018-03-09|work=tw.wikiinc.net|language=zh-TW|archive-date=2018-07-04|archive-url=https://web.archive.org/web/20180704093041/http://tw.wikiinc.net/%E5%84%84%E5%BA%B7%E7%94%9F%E7%89%A9%E7%A7%91%E6%8A%80%E8%82%A1%E4%BB%BD%E6%9C%89%E9%99%90%E5%85%AC%E5%8F%B8/28516838|dead-url=yes}}</ref>。

==專業==
*[[癌症生物學|癌症生物學]] (Cancer Biology)
*[[分子生物學|分子生物學]] (Microbiology)
*[[華陽複方|華陽複方]]( Selected Vegetables,SV)

==研究團隊==
*[[孫士銧|孫士銧]]
*[[孫達士|孫達士]]
*[[楊思標|楊思標]]
*[[林瑞雄|林瑞雄]]
*[[毛仁淡|毛仁淡]]
*[[Henry_sacks|Henry sacks]]
*[[Thomas_M._Fasy|Thomas M. Fasy]]

==著作==
*1.Sachdev, P., Zeng, L. and Wang, L.-H. (2002). Distinct role of hosphotidylinositol 3-kinase and Rho family GTPases in Vav3-induced cell transformation, cell motility, and morphological changes. J. Biol. Chem. 277:17638-17648.
*2.Le, Maithao N., Kohanski, Ronald.A., Wang, Lu-Hai and Sadowski, Henry (2002). Dual mechanism of signal transduccer and activator of transcription 5 (Stat5) activation by the insulin receptor.  Molecular Endocrinology 16:2764-2779.
*3.Uttamsingh, Shailaja, Zong, Cong S. and Wang, Lu-Hai (2003). Matrix-independent activation of PI3 kinase, Stat3 and cyclin A-associated Cdk2 is essential for anchorage independent growth of v-Ros transformed chicken embryo fibroblasts. J. Biol. Chem. 278:18798-18810.
*4.Wang, Lu-Hai (2004) Molecular signaling regulating anchorage-independent growth of cancer cells. The Mount Sinai J. of Medicine 71:361-367.
*5.Lopewz-Bergami, P., Hasen H., Bhoumik, A, Zhang, W., Wang L.-H., and Ronai, Z. (2005) Receptor for RACK1 mediates activation of JNK by protein kinase C. Mol. Cell 19:309-320.
*6.Zhang, W., Zong, C. S., Hermanto, U., Lopez-Bergami, P., Ronai, Z. and Wang, L.-H. (2005) RACK1 recruits STAT3 specifically to insulin and IGF-1 receptors for activation, which is important for regulating anchorage independent growth. Mol. Cell Biol. 26:413-424.
*7.Yio, X., Diamond, M., Zhang, J.-Y., Weinstein, H., Wang, L.-H., Werther, L. and Itzkowitz, S. (2006) Trefoil factor family-1 mutations enhance gastric cancer cell invasion through distinct signaling pathways. Gastroenterology  130:1696-706.
*8.Dong, Z., Liu, Y., Lu, S., Wang, A., Lee, K., Wang, L.-H., Revdo, M. and Lu, S. (2006) Vav3 oncogene is overexpressed and regulates cell growth and androgen receptor activity in human prostate cancer.  Mol Endo. 20:2315-2325.
*9.Cheng, G. Z., Chan, J., Sun, C.D., Wang, Q., Zhang, W. and Wang, L.-H. (2007). Twist transcriptionally upregulates AKT2 in invasive breast cancer cells leading to increased migration and survival. Cancer Research 67:1979-87.
*10.Wang, L.-H., Chan, J. L.-K. and  Li, W. (2007) Rapamycin together with herceptin significantly increased anti-tumor efficacy compared to either alone in ErbB2 over expressing breast cancer cells. Intl. J. Cancer 157-164.
*11.K Masker, A. Golden, C. J. Gaffney, V. Mazack, W. F. Schwindinger, W. Zhang, L.-H. Wang, D.J. Carey and M. Sudol (2007). Transcriptional profile of Rous Sarcoma Virus transformed chicken embryo fibroblasts reveals new signaling targets of viral src. Virology 364:10-20.
*12.Cheng G Z, Zhang W, Wang L.-H. (2008) Regulation of cancer cell survival, migration and invasion by Twist: AKT2 comes to interplay. Cancer Research 68:957-960.
*13.Uttamsingh, S, Bao, X., Nguyen, K. T., Bhanot M., Chan J. L.-K., Liu F, Chu T. and Wang, L-H. (2008) Synergistic effect between EGF and TGF-1 in inducing oncogenic properties of intestinal epithelial cells. Oncogene 27:2626-2634.
*14.Cheng G Z, Zhang W, Sun M, Wang, Q, Coppola D, Costanzo C, Xu L M, Chan J, Cheng J Q, Wang L-H. (2008) Twist is Induced by Activation of STAT3 and Mediates STAT3 Oncogenic Function. JBC 283:14665-73.
*15.Cheng G. Z., Park S., Shu S., He L., Kong W., Zhang W., Yuan Z., Wang L.-H., Cheng J. Q. (2008) Advances of AKT pathway in human oncogenesis and as a target for anti- cancer drug discovery. Current Cancer Drug Targets 8:2-6.
*16.Wang, L.-H. (2008) Overview of modular domains and adaptor proteins, pp1-32 in “Adaptor proteins and cancer” Ed. M. Georges, Transworld Research Network, Trivandrum-695 023, Kerala, India.
*17.Zhang W., Cheng G. Z., Hermanto U., Zong C. S., Chan J., Cheng J. and Wang, L.-H. (2008) RACK1 and CIS mediate the degradation of BimEL in cancer cells. JBC 283:16416-26.
*18.Schlosshauer, P.W., Li, W., Lin, Kai-Ti., Chan, J. L-K. and Wang, L.-H. (2009) Rapamycin by itself and additively in combination with carboplatin inhibits the growth of ovarian cancer cells. Gynecologic Oncology 114:516-522.
*19.Jiang SS, Fang WT, Hou YH, Huang SF, Yen BL, Chang JL, Li SM, Liu HP, Liu YL, Huang CT, Li YW, Jang TH, Chan SH, Yang SJ, Hsiung CA, Wu CW, Wang LH, Chang IS. Upregulation of SOX9 in lung adenocarcinoma and its involvement in the regulation of cell growth and tumorigenicity. Clin Cancer Res. 2010 Sep 1;16(17):4363-73. doi: 10.1158/1078-0432.CCR-10-0138. Epub 2010 Jul 22
*20.Tsai YC, Pestka S, Wang LH, Runnels L W, Wan S, Lyu YL and Liu L F. (2011) Interferon-β Autocrine Signaling Promotes Oncogenic Ras-Induced Cell Transformation.  PLoS ONE 6(8): e24291, 1-8.
*21.Lin, K.T. , Gong, J, Jang, T. H., Chen, H. J., Li, J. F. and Wang, L-H. (2012) EphA2-Vav3-Rac1 signaling mediates migratory and invasive behavior of prostate cancer cells and correlates with the disease progression Cancer Research 72 (12):3000-3009.
*22.Lin, K.-Y, Wang, L-H., Hsen, Y. -C., Fung, C. -L., Yang, H. -L., Senthil Kumar, K.J., Tai, C. and Uen, Y.-H. (2012) Clinical significance of creased guanine nucleotide exchange factor Vav3 expression in human gastric cancer. Molecular Cancer Research 10(6): 750-759.
*23.HJ Shih, HH Chen, YA Chen, MH Wu, GG Liou, WW Chang, LY Chen, LH Wang, HL Hsu. Targeting MCT-1 oncogene inhibits Shc pathway and xenograft tumorigenicity. Oncotarget. 2012 Nov;3(11):1401-1415.
*24.Shih HJ, Chu KL, Wu MH, Wu PH, Chang WW, Chu JS, Wang LH, Takeuchi H, Ouchi T, Hsu HL. The involvement of MCT-1 oncoprotein in inducing mitotic catastrophe and nuclear abnormalities. Cell Cycle. 2012 Mar 1;11(5):934-952
*25.Yeh YM, Chuang CM, Chao KC, Wang LH. (2013) MicroRNA-138 suppresses ovarian cancer cell invasion and metastasis by targeting SOX4 and HIF-1α. Int J Cancer. Aug 15;133(4):867-78.
*26.Huang WC, Chan SH, Jang TH, Chang JW, Ko YC, Yen TC, Chiang SL, Chiang WF, Shieh TY, Liao CT, Juang JL, Wang HC, Cheng AJ, Lu YC, Wang LH. (2014) miRNA-491-5p and GIT1 serve as modulators and biomarkers for oral squamous cell carcinoma invasion and metastasis. Cancer Res. Feb 1;74(3):751-64.
*27.Chan SH, Huang WC, Chang JW, Chang KJ, Kuo WH, Wang MY, Lin KY, Uen YH, Hou MF, Lin CM, Jang TH, Tu CW, Lee YR, Lee YH, Tien MT, Wang LH. (2014) MicroRNA-149 targets GIT1 to suppress integrin signaling and breast cancer metastasis. Oncogene. Sep 4;33(36):4496-507
*28.Lin KT, Yeh YM, Chuang CM, Yang SY, Chang JW, Sun SP, Wang YS, Chao KC, Wang LH. (2015) Glucocorticoids mediate induction of microRNA-708 to suppress ovarian cancer metastasis through targeting Rap1B. Nat Commun. Jan 8;6:5917.
*29.Chan SH, Wang LH. (2015) Regulation of cancer metastasis by microRNAs. J Biomed Sci. Jan 23;22:9.

==參考資料==
* [https://web.archive.org/web/20140408224254/http://www.nhri.org.tw/NHRI_WEB/nhriw1001Action.do?emp_cd=970133 國家衛生研究院王陸海主頁]
* [https://web.archive.org/web/20140408224107/http://www.nhri.org.tw/NHRI_WEB/nhriw001Action.do?status=Show_Dtl&nid=20120925926364640000&uid=20081203749159640000 國家衛生研究院王陸海院士TWAS當選新聞稿]
* [https://web.archive.org/web/20160304223049/http://www.tcmp.com.tw/chinese/Item_content_show.asp?NO=1624%2F  植物複方治肺腺癌 進入第三期人體實驗]
* [https://web.archive.org/web/20190619083639/https://www.sinica.edu.tw/manage/gatenews/showsingle.php?_op=%3Frid%3A3349  本院宣布第28屆新任院士名單]

==外部連結==
* [https://web.archive.org/web/20140419061214/http://www.nhri.org.tw/  國家衛生研究院]
* [http://www.sinica.edu.tw/  中央研究院] {{Wayback|url=http://www.sinica.edu.tw/ |date=20161104012659 }}
* [https://web.archive.org/web/20141025002353/http://www.tcmp.com.tw/chinese/index.asp  中草藥資料庫]

{{中央研究院第二十八届院士}}
{{DEFAULTSORT:H}}
[[Category:美国华人学者|Category:美国华人学者]]
[[Category:台灣生物學家|Category:台灣生物學家]]
[[Category:中央研究院生命科學組院士|Category:中央研究院生命科學組院士]]
[[Category:王姓|L]]
[[Category:國家衛生研究院院長|Category:國家衛生研究院院長]]
[[Category:中國醫藥大學教授|Category:中國醫藥大學教授]]
[[Category:美国肿瘤学家|Category:美国肿瘤学家]]
[[Category:台灣腫瘤學家|Category:台灣腫瘤學家]]
[[Category:加利福尼亞大學柏克萊分校校友|Category:加利福尼亞大學柏克萊分校校友]]
[[Category:國立臺灣大學生物資源暨農學院校友|Category:國立臺灣大學生物資源暨農學院校友]]
[[Category:斗南鎮人|Category:斗南鎮人]]
[[Category:國立嘉義高級中學校友|Category:國立嘉義高級中學校友]]